Loading...
Pharmis Sarl — Erlotinib Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #10 buyer for Erlotinib · $62.5K import value · 3 shipments · MOROCCO · DGFT Verified
Pharmis Sarl is the #10 importer of Erlotinib from India with $62.5K in import value and 3 verified shipments. Pharmis Sarl holds a 2.3% market share in Erlotinib imports based in MOROCCO. Overall, Pharmis Sarl imports 2 pharmaceutical products worth $1.1M across 1 therapeutic categories.
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| NATCO PHARMA LIMITED | $547.2K | 11 | 3 |
| MSN LABORATORIES PRIVATE LIMITED | $529.7K | 32 | 6 |
| VEXXA LIFESCIENCES PVT. LTD. | $253.4K | 16 | 1 |
| CIPLA LIMITED | $200.0K | 4 | 2 |
| ALEMBIC PHARMACEUTICALS LIMITED | $129.5K | 9 | 1 |
| RELIANCE LIFE SCIENCES PRIVATE LIMITED | $102.9K | 7 | 3 |
| UNITED BIOTECH PRIVATE LIMITED | $98.8K | 7 | 4 |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | $54.2K | 12 | 3 |
| VEXXA LIFESCIENCES PRIVATE LIMITED | $37.4K | 3 | 1 |
| JODAS EXPOIM PRIVATE LIMITED | $31.3K | 5 | 1 |
India's top Erlotinib suppliers include NATCO PHARMA LIMITED, MSN LABORATORIES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT. LTD.. These companies represent the primary source of Erlotinib exports from India, serving buyers like Pharmis Sarl in MOROCCO and other global markets.
Buyers ranked immediately above and below #10 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | WIN PHARMACY CO LTD | MYANMAR | $89.4K | 3 | $29.8K |
| 9 | MEDPRO PHARMACEUTICA (PTY) LTD, | SOUTH AFRICA | $78.8K | 2 | $39.4K |
| 10 | PHARMIS SARL ★ | MOROCCO | $62.5K | 3 | $20.8K |
| 11 | MSN LABS PERU SAC CAL. | PERU | $53.3K | 3 | $17.8K |
| 12 |
India exported $1.2M worth of Erlotinib through 336 shipments from 94 suppliers to 55 countries, serving 144 buyers globally. Pharmis Sarl imports $62.5K of this total, accounting for 2.3% of India's Erlotinib exports with 3 shipments from MOROCCO.
Pharmis Sarl's average Erlotinib order value is $20.8K per consignment, based on 3 shipments totaling $62.5K. Pharmis Sarl is based in MOROCCO and ranks #10 among all Erlotinib importers from India by value.
Top Indian Erlotinib suppliers include NATCO PHARMA LIMITED ($547.2K), MSN LABORATORIES PRIVATE LIMITED ($529.7K), VEXXA LIFESCIENCES PVT. LTD. ($253.4K), CIPLA LIMITED ($200.0K), ALEMBIC PHARMACEUTICALS LIMITED ($129.5K). These companies represent the primary source of Erlotinib exports from India.
Pharmis Sarl ranks #10 among 144 Erlotinib importers from India with a 2.3% market share. The top 3 importers are VE PHARMA INC. ($185.1K), VE PHARMA INC ($142.3K), J. KNIPPER & COMPANY ($106.9K). Pharmis Sarl processed 3 shipments from MOROCCO.
Pharmis Sarl also imports these advanced oncology products. Each links to the detailed product page.
Pharmis Sarl imports 2 products worth $1.1M. Beyond Erlotinib, top products include Lenalidomide. View the complete Pharmis Sarl profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Erlotinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for Pharmis Sarl's Erlotinib imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Pharmis Sarl
Full Company Profile →
2 products · $1.1M total trade · 1 categories
| 'TO THE ORDER |
| CHILE |
| $43.3K |
| 2 |
| $21.7K |
Pharmis Sarl ranks #10 among 144 Erlotinib importers from India. Average shipment value of $20.8K compared to the market average of $8.5K. The closest competitors by value are WIN PHARMACY CO LTD and MEDPRO PHARMACEUTICA (PTY) LTD,.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 55+ countries, 144+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for Pharmis Sarl.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Erlotinib. For current order-level data, contact TransData Nexus.